Contact
Please use this form to send email to PR contact of this press release:
Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037
TO:
Please use this form to send email to PR contact of this press release:
Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037
TO: